Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-02-24 @ 3:14 PM
Study NCT ID:
NCT02087059
Status:
COMPLETED
Last Update Posted:
2016-07-11
First Post:
2014-03-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-12
First Submit QC Date:
None
Study First Post Date:
2014-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-11
Results First Submit QC Date:
None
Results First Post Date:
2016-07-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-26
Last Update Post Date:
2016-07-11
Last Update Post Date Type:
ESTIMATED